Position in AMLX
as of Mar 31, 2026
· filed May 29, 2026
Position Value
$115,159,859
+$15,078,485 QoQ
Shares Held
8,284,882
0.0% QoQ
Ownership
7.45%
of shares outstanding
% of Portfolio
2.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Derivatives in AMLX
reported options exposure · as of Mar 31, 2024CallValue
$4,768,715
CallShares
1,679,125
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PERCEPTIVE ADVISORS LLC holds $200,430,720 across 5 Drug Manufacturers - Specialty & Generic names. AMLX ranks #1 (57.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
8,284,882 | $115,159,859 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
7,434,033 | $70,771,994 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
65,050 | $8,569,687 | |
| 4 | EOLS |
Evolus, Inc.
|
1,286,862 | $5,289,002 | |
| 5 | CPIX |
Cumberland Pharmaceuticals Inc
|
196,978 | $640,178 |
All Filings in AMLX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $115,159,859 | 8,284,882 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $100,081,374 | 8,284,882 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $121,662,640 | 8,952,365 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $121,662,640 | 8,952,365 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $50,654,159 | 7,902,365 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $27,875,191 | 7,874,348 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $25,607,035 | 6,774,348 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,887,102 | 2,125,649 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $852,000 | 300,000 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $4,768,715 | 1,679,125 | Call | Sole | 2024-08-06 | |
| 2023-12-31 | $27,513,520 | 1,869,125 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $49,233,264 | 2,688,873 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $105,130,432 | 4,873,919 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $177,056,454 | 6,034,644 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $224,963,904 | 6,088,333 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $154,037,728 | 5,472,033 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $68,188,258 | 3,540,408 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $18,942,274 | 1,474,107 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||